2. Status og generelle nyheder fra DEKS - Dansk Institut for Ekstern ...
2. Status og generelle nyheder fra DEKS - Dansk Institut for Ekstern ...
2. Status og generelle nyheder fra DEKS - Dansk Institut for Ekstern ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Klinisk Mikrobiol<strong>og</strong>i<br />
____________________________________________________________________________________________________________<br />
Kvalitetskontrolmaterialer<br />
2025 UK HBs Ag, QC 1; 4 ml human plasma.<br />
2030 UK Anti-CMV, QC 1; 4 ml human plasma.<br />
P-Hepatitis B virus s-antigen<br />
2035 UK<br />
2061 UK<br />
2036 UK<br />
2038 UK<br />
2028 UK<br />
2024 UK<br />
2027 UK<br />
2018 UK<br />
2019 UK<br />
2020 UK<br />
2047 UK<br />
2022 UK<br />
2023 UK<br />
2060 UK<br />
2066 UK<br />
P-Cytomegalovirus-antistof<br />
Anti-HAV, total, QC 1, 4 ml human plasma.<br />
P-Hepatitis A virus-antistof<br />
Anti-HAV IgM QC 2; 1 ml human plasma<br />
P-Hepatitis A virus-antistof(IgM)<br />
Anti-HBc, total, QC 1, 4 ml human plasma.<br />
P-Hepatitis B virus c-antistof<br />
Anti-HBc IgM, QC 1, 1 ml human plasma.<br />
P-Hepatitis B virus c-antistof(IgM)<br />
Anti-HBe, QC 1; 4 ml human plasma.<br />
P-Hepatitis B virus e-antistof<br />
Anti-HBs, QC 1, 4 ml human plasma.<br />
P-Hepatitis B virus s-antistof<br />
Anti-HCV, QC 1; 4 ml human plasma.<br />
P-Hepatitis C virus-antistof<br />
Anti-HIV-1, QC 1; 4 ml human plasma.<br />
P-Human immundefektvirus 1-antistof<br />
Anti-HIV-1, QC 2; 4 ml human plasma.<br />
P-Human immundefektvirus 1-antistof<br />
Anti-HIV-1, QC 3; 4 ml human plasma.<br />
P-Human immundefektvirus 1-antistof<br />
Anti-HIV-1, QC 5: 4 ml human plasma.<br />
P-Human immundefektvirus 1-antistof<br />
Anti-HIV-2, QC 2; 4 ml human plasma<br />
P-Human immundefektvirus 2-antistof<br />
Anti-HIV-2, QC 3; 4 ml human plasma.<br />
P-Human immundefektvirus 2-antistof<br />
Anti-HSV2 QC 1; 4 ml human plasma<br />
P-Herpes simplexvirus 2-antistof<br />
Anti-HSV 1, QC 1; 4 ml human plasma.<br />
P-Herpes simplexvirus 1-antistof<br />
2049 UK HIV-1 p24 Antigen, QC 1; 4 ml human<br />
plasma.<br />
P-Human immundefektvirus 1(Ag;p24)<br />
2050 UK HIV-1 p24 Antigen, QC 2; 4 ml human<br />
plasma.<br />
P-Human immundefektvirus 1(Ag;p24)<br />
43<br />
2026 UK<br />
HBs Ag, QC 2; 4 ml human plasma.<br />
P-Hepatitis B virus s-antigen<br />
2078 UK Influenza A H5 positiv kontrol, QC 1; 2 x<br />
0,8 ml.<br />
2077 UK Negativt kvalitetskontrolserum, QC1; 4 ml<br />
human plasma.<br />
2059 UK<br />
2065 UK<br />
2058 UK<br />
Anti-Syphilis QC 1; 4 ml human plasma<br />
P-Standard Test Syfilis<br />
Anti-Syphilis QC 2; 4 ml human plasma.<br />
P-Standard Test Syfilis<br />
Anti-VZV QC 1; 4 ml human plasma<br />
P-Varicella-zostervirus-antistof<br />
3157 NL Virus screening PeliSpy HBs Ag, HCV Ab,<br />
HIV-1/2 Ab, HTLV I/II Ab, 10 x 5 ml flydende human<br />
serum.<br />
P-Hepatitis B virus s-antigen<br />
P-Hepatitis C virus-antistof<br />
P-HTLV type I-antistof+HTLV type II-antistof<br />
P-Human immundefektvirus-antistof<br />
Kvalitetssikringspr<strong>og</strong>rammer, Bakteriol<strong>og</strong>i<br />
3080 UK Antibiotikabestemmelse i serum, 12 uds., á<br />
1-7 prøver á 0,5-1,0 ml.<br />
Oplys de ønskede antibiotika.<br />
P-Amikacin<br />
P-Flucytosin<br />
P-Gentamicin<br />
P-Netilmicin<br />
P-Teicoplanin<br />
P-Tobramycin<br />
P-Vancomycin<br />
3088 FIN Antistreptolysintiter (AST) kvalitativ <strong>og</strong><br />
kvantitativ, 4 uds. á (2 - 3) x 0,6 ml flydende human<br />
serumprøver.<br />
P-Streptolysin O-antistof (Antistreptolysintiter)<br />
3197 FIN Bloddyrkning, ident. & resistens. 4 uds. á 2<br />
prøver frysetørret materiale.<br />
B-Bacterium+fungus (Bloddyrkning, identifikation <strong>og</strong><br />
resistens)<br />
3725 FIN Borrelia burgdorferi. 4 uds. á 2-3 flydende<br />
humane sera á 0,5 ml. Pilotstudie 2008.<br />
____________________________________________________________________________________________________________
Change language